As mentioned, we have shown that Sirt2 knockout mice with a KRASG12D mutation background develop pancreatic cancer, suggesting Sirt2 knockout is susceptible for pancreatic cancer11. This evidence concerns the gene SIRT2 and familial pancreatic carcinoma.